TY - JOUR
T1 - Myron Gordon Award paper
T2 - Microbes, T-cell diversity and pigmentation
AU - Le Poole, I. Caroline
N1 - Funding Information:
Members of the Le Poole Lab, past and present, are gratefully acknowledged for their contributions to our research program and Dr. H.E.N. Bergmans, retired Senior Scientist, GMO Office, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands, and current consultant on GMO biosafety with Ameco Environmental Services. The studies were supported in part by NCI RO1CA191317 to CLP, 1R21CA245447 to Diana Saleiro, PhD and P30 AR075049 to Amy Paller, MD. The award honored by this paper is named for Dr. Myron Gordon (November 13, 1899–March 12, 1959). Myron was a zoologist and geneticist. He studied to model melanoma biology and help understand genetic factors and heredity involved in melanoma formation (Ghadially & Gordon, 1957 ; Gordon, 1947 ). Myron was a graduate student at Cornell before moving to New York University to perform his ground‐breaking work. The species is named for him, and the IFPCS has established an award, also named after Dr Gordon, presented at tri‐Annual IPCC meetings around the globe. The figure was generated in biorender.com. Finally, the author would like to acknowledge to the body of knowledge in the field of pigmentation research, microbiology, and autoimmunity and antitumor immunity. Xyphophorus Xyphophorus gordoni
Publisher Copyright:
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021
Y1 - 2021
N2 - Melanocytes are static, minimally proliferative cells. This leaves them vulnerable in vitiligo. Yet upon malignant transformation, they form vicious tumors. This profound switch in physiology is accompanied by genetic change and is driven by environmental factors. If UV exposure in younger years supports malignant transformation and melanoma formation, it can likewise impart mutations on melanocytes that reduce their viability, to initiate vitiligo. A wide variety of microbes can influence these diametrically opposed outcomes before either disease takes hold. These microbes are vehicles of change that we are only beginning to study. Once a genetic modification occurs, there is a wide variety of immune cells ready to respond. Though it does not act alone, the T cell is among the most decisive responders in this process. The same biochemical process that offered the skin protection by producing melanin can become an Achilles heel for the cell when the T cells target melanosomal enzymes or, on occasion, neoantigens. T cells are precise, determined, and consequential when they strike. Here, we probe the relationship between the microbiome and its metabolites, epithelial integrity, and the activation of T cells that target benign and malignant melanocytes in vitiligo and melanoma.
AB - Melanocytes are static, minimally proliferative cells. This leaves them vulnerable in vitiligo. Yet upon malignant transformation, they form vicious tumors. This profound switch in physiology is accompanied by genetic change and is driven by environmental factors. If UV exposure in younger years supports malignant transformation and melanoma formation, it can likewise impart mutations on melanocytes that reduce their viability, to initiate vitiligo. A wide variety of microbes can influence these diametrically opposed outcomes before either disease takes hold. These microbes are vehicles of change that we are only beginning to study. Once a genetic modification occurs, there is a wide variety of immune cells ready to respond. Though it does not act alone, the T cell is among the most decisive responders in this process. The same biochemical process that offered the skin protection by producing melanin can become an Achilles heel for the cell when the T cells target melanosomal enzymes or, on occasion, neoantigens. T cells are precise, determined, and consequential when they strike. Here, we probe the relationship between the microbiome and its metabolites, epithelial integrity, and the activation of T cells that target benign and malignant melanocytes in vitiligo and melanoma.
KW - innate immune cells
KW - malignant transformation
KW - microbiome
KW - pigmentation
KW - T cells
UR - http://www.scopus.com/inward/record.url?scp=85099743274&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099743274&partnerID=8YFLogxK
U2 - 10.1111/pcmr.12957
DO - 10.1111/pcmr.12957
M3 - Review article
C2 - 33438345
AN - SCOPUS:85099743274
SN - 1755-1471
VL - 34
SP - 244
EP - 255
JO - Pigment Cell and Melanoma Research
JF - Pigment Cell and Melanoma Research
IS - 2
ER -